An Investor's Guide to Pfizer's 2Q15 Earnings (Continued from Prior Part) Profitability margins As discussed earlier, Pfizer’s (PFE) revenues fell 7% year-over-year during 2Q15. This has certainly affected the company’s profitability. The company’s reported net income fell by ~10% to $2.6 billion in 2Q15, while the operating income fell by ~6% to $3.53 billion in the same period. The company has beat analyst estimates over the last four quarters for its net income. The operating income for 2Q15 was ~$3.53 billion, which was ~9% higher than the analyst estimates of $3.23 billion. The company’s gross profit margin improved by ~0.9% to 81.6% in 2Q15 over 2Q14 due to lower cost of sales. However, the operating profit margin fell by ~1.4% to 29.9% in 2Q15 as compared to 31.3% in 2Q14. This was mainly due to... More